The NAD+ Opportunity for Med Spas

nad+ sits in an unusual commercial position. it has genuine consumer awareness driven by years of longevity media coverage, it carries some of the highest ticket prices in a med spa menu, and it has natural repeat behavior built into how people buy it. most operators we work with are running it as a single in-clinic service and leaving the majority of the revenue on the table.

this is a market and business guide. we are not going to describe what nad+ does physiologically, make health claims, or give dosing guidance. those are provider and regulatory questions, and nothing here is medical or legal advice. what we can talk about is demand, formats, margin, and how to build the offer.

why NAD+ is a strong category for med spas

four commercial properties make it work. it has high perceived value, which supports premium pricing. it has an existing consumer vocabulary — clients ask for it by name because of podcast and press exposure, not because you educated them. it has inherent repeat structure, since people who buy it once tend to buy it on a cadence. and it fits naturally alongside services a med spa already delivers, so incremental delivery cost is low.

the strategic value is bigger than the line item. nad+ clients skew toward the longevity-and-optimization buyer, which is the highest-ltv customer profile in this industry. they buy memberships, they buy multiple categories, and they are far less price sensitive than the aesthetics-only client. capturing that segment through nad+ changes your whole customer mix.

the four formats and what each one is for

operators tend to think of nad+ as one product. commercially it is four, and each plays a different role.

• —IV infusion in clinic — the highest ticket and the flagship. long chair time, provider oversight, strong margin per session, low frequency
• —subcutaneous injectable dispensed under a provider — lower ticket, much higher frequency, and the format that converts an IV client into a monthly relationship
• —oral and sublingual consumer products — the ecommerce and subscription engine. shippable, no clinical delivery cost, and the format that lets you monetize outside your geography
• —precursor supplement formats — the broadest consumer category and the easiest to sell online, with the important caveat that the dietary supplement status of specific precursor ingredients has been contested and needs to be verified before you build a SKU on one

that last point matters commercially. the regulatory status of certain nad precursor ingredients as dietary supplements has been the subject of fda action and industry dispute, which means an ingredient that was freely sold as a supplement may not stay in that lane. before you commit to packaging, inventory, and a subscription program around a specific precursor, have counsel confirm its current status. this is exactly the kind of thing that turns into dead inventory.

the compliance line

the practical boundary is delivery method and claims. injectable and infused formats belong to your licensed medical layer — provider evaluation, appropriate standing orders or prescriptions, licensed pharmacy or supplier sourcing, and documentation. consumer-shippable formats live under whatever regulatory framework their ingredients actually occupy, with claims constrained accordingly.

• —no disease treatment, cure, or prevention claims in any channel — this is where supplement brands in adjacent categories have drawn warning letters
• —no implying a shippable consumer product is equivalent to a clinical service
• —keep your medical service marketing and your consumer product marketing structurally separate, including separate landing pages and separate claims review
• —if any product in the line is research use only, label it that way consistently and never merchandise it next to consumer products
• —brief influencers and affiliates in writing; their claims become your claims in practice

pricing and margin structure

the mistake operators make is pricing nad+ services as a single transaction and never building the ladder. a one-off iv is a good day. a ladder is a business.

1. 1.entry service priced to be tried, not to maximize first-visit revenue
2. 2.a package or series at a per-session discount that pre-commits the client to a cadence
3. 3.a membership that bundles nad+ with the other services and products this client already wants
4. 4.an at-home subscription format that generates revenue in the weeks between clinic visits
5. 5.an attach product at checkout that raises AOV without adding chair time

the leverage is in steps three through five. clinic services are capped by chair hours and staff. the at-home and subscription layer is not, and it carries better contribution margin because there is no delivery labor. we routinely see med spas where the shippable product line eventually out-earns the service that introduced the client to it.

sourcing and quality expectations

for injectable and infused formats, your sourcing is a licensed pharmacy or supplier question and your due diligence should look like any pharmaceutical supply relationship: licensure verification in every state you operate, inspection history, lot-level potency and sterility documentation with named analytical methods, stability basis for the labeled dating, and a documented recall procedure.

for consumer formats, you are doing supplement-grade diligence: cGMP-compliant manufacturing, third-party identity and potency verification per lot, heavy metals and microbial testing, allergen and cross-contamination controls, and stability data supporting your shelf life. ask for the certificate on your lot, not a representative one. verify the lab is real.

marketing NAD+ without making claims

the good news is that this category has enough existing consumer awareness that you do not need to make claims to sell it. people arrive already interested. your job is to be the credible provider, not to convince them the category is real.

• —lead with experience and operation: what the appointment looks like, how long it takes, who administers it, what the room is like, transparent pricing
• —use the longevity and optimization positioning that this buyer already identifies with, without asserting outcomes
• —run high creative volume — this is a visually rich service and iterating on setting, staff, and format beats iterating on copy
• —capture email and sms at every touchpoint; the at-home line is sold almost entirely through owned channels
• —put the membership offer in front of every first-time nad+ client within 72 hours of their visit

operator mistakes we see repeatedly

1. 1.running nad+ as a standalone service with no series, membership, or at-home follow-on
2. 2.pricing the entry service so high that trial never happens
3. 3.building a supplement SKU on a precursor ingredient without verifying its current regulatory status
4. 4.letting staff and creators make health claims the brand carefully avoided
5. 5.underestimating chair time, so a high-ticket service quietly destroys clinic throughput
6. 6.never capturing the email list, which means the shippable product line has no audience to launch into

the nad+ client is the highest-value customer in the building. most med spas sell them one service and never speak to them again.

the fastest way to expand this line

if you already run nad+ in clinic, the highest-return move is not more ad spend. it is building the at-home format and the membership, then launching both into the client list you already have. that revenue has no acquisition cost, no chair time, and it makes every future paid acquisition dollar work harder because your ltv goes up. do that before you scale traffic.